Skip to content

Exploring the neural mechanisms of tDCS-VR technology for post-stroke cognitive impairment based on fNIRS

Exploring the neural mechanisms of tDCS-VR technology for post-stroke cognitive impairment based on fNIRS

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070580
Enrollment
Unknown
Registered
2023-04-17
Start date
2022-01-01
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-stroke cognitive impairment

Interventions

Conventional cognitive rehabilitation group:Conventional cognitive rehabilitation
VR group:Virtual reality
tDCS-VR group:tDCS-VR

Sponsors

The First Affiliated Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18-70 years old; ; (2) a stable condition with clear consciousness; (3) an MMSE score of 10-26; (4) cognitive impairment on initial investigation; (5) no previous history of mental illness; (6) cooperation with all assessments and examinations and voluntary signing of an informed consent form; (7) a stroke diagnosis in accordance with the diagnosis of ischemia or hemorrhage established by the 1995 Cerebrovascular Disease Conference and confirmed by CT or MRI. The diagnostic criteria for PSCI were based on the criteria in the 5th edition of the Diagnosis and Manual of Mental Disorders.

Exclusion criteria

Exclusion criteria: (1) severe illness or unconsciousness; (2) MMSE score less than 10; (3) metal implants or pacemakers in the head, history of epilepsy or seizures; (4) previous history of mental illness severe aphasia or severe hearing or visual impairment; (5) concurrent myocardial infarction or combination of severe liver and kidney function, severe infection, severe diabetes mellitus; (6) inability to cooperate with all assessments and examinations or refusal to sign an informed consent form.

Design outcomes

Primary

MeasureTime frame
Overall cognitive function;

Secondary

MeasureTime frame
Frontal lobe function;Visuo-spatial ability;Attention;Memory;Speech function;Ability of daily living;Oxygenated hemoglobin and deoxygenated hemoglobin in cerebral cortex;

Countries

China

Contacts

Public ContactXiaoping Cheng

The First Affiliated Hospital of Fujian Medical University

cxp36@fjmu.edu.cn+86 13400587857

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 19, 2026